Short course montelukast for intermittent asthma in children: economic analysis of the PRE-EMPT study

D. Price, C. F. Robertson, R. L. Henry, C. Mellis, D. Fitzgerald, N. Glasgow, A. Lee, J. Turner, M. Schulz, I. Noble (Aberdeen, United Kingdom; Melbourne, Sydney, Canberra, Australia)

Source: Annual Congress 2004 - Primary care: asthma treatments
Session: Primary care: asthma treatments
Session type: Thematic Poster Session
Number: 1984
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Price, C. F. Robertson, R. L. Henry, C. Mellis, D. Fitzgerald, N. Glasgow, A. Lee, J. Turner, M. Schulz, I. Noble (Aberdeen, United Kingdom; Melbourne, Sydney, Canberra, Australia). Short course montelukast for intermittent asthma in children: economic analysis of the PRE-EMPT study. Eur Respir J 2004; 24: Suppl. 48, 1984

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short term improvement of asthma control by omalizumab in difficult-to-treat asthmatic children: A French national survey
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
Source: Eur Respir J 2013; 42: 1224-1233
Year: 2013



X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Predicting asthma exacerbations in children – A real life observational study
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015

Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010



Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
Source: Eur Respir J, 56 (4) 2000151; 10.1183/13993003.00151-2020
Year: 2020



A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Clinical benefits and safety of long term treatment with Montelukast in children with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 525s
Year: 2002

Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018

Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Factors influencing adherence to beclomethasone in children with persistent asthma in a low-income country: a randomized concurrent cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 450s
Year: 2005

Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Adherence to beclomethasone in children with persistent asthma in a low-income country: a randomized concurrent cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 162s
Year: 2005

Medication use in children with asthma: a case control study
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001

Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009